Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.
What is the purpose of this trial?
This study aims to determine the efficacy and safety of QAW039 (Dose 1 and Dose 2), compared with placebo, when added to GINA steps 4 and 5 standard-of- care (SoC) asthma therapy (GINA 2015) in each of the groups (patients with severe asthma and high eosinophil counts and all patients with severe asthma).
- Ages12 years and older
- Trial withNovartis Pharmaceuticals
- Start Date07/31/2018
- End Date10/16/2019
- Last Updated09/18/2018
- Study HIC#2000023028